Skip to content

IDESPHARMA

Active
Private limited companyfounded 2021active for 5 yearsDageraadstraat(Kok) 11, 8670 Koksijde, BelgiumKBO/BCE: BE 0764.318.824
Summary

IDESPHARMA has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €353,392 and a net result of -€6,436. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 38% of 12,650 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Financials · financial year 2025, abbreviated format

Equity
€353,392▼ 1.8%
2024 · €359,829
Total assets
€1.3m▼ 1.8%
2024 · €1.4m
Net result
-€6,436
2024 · €97,266
Working capital
€259,776▼ 0.6%
2024 · €261,394
Trend over the years

2022 to 2025, 4 financial years

The operating result turns negative in 2025: a loss of €3,651 after €149,395 in 2024, the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€0.004m 2025 Net result-€0.006m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€0.2m-€0.2m▼ 16.9%€0.1m▼ 9.6%-€0.004m
Net result€0.1mabove the sector's middle half-€0.1mwithin the sector's middle half▼ 19.1%€0.1mwithin the sector's middle half▼ 15.5%-€0.006mbelow the sector's middle half
Equity€0.1mwithin the sector's middle half-€0.3mwithin the sector's middle half▲ 78.1%€0.4mwithin the sector's middle half▲ 37.0%€0.4mwithin the sector's middle half▼ 1.8%
Total assets€0.4mbelow the sector's middle half-€0.5mbelow the sector's middle half▲ 22.1%€1.4mwithin the sector's middle half▲ 184%€1.3mwithin the sector's middle half▼ 1.8%
Debt€0.2m-€0.2m▼ 11.5%€1.0m▲ 361%€1.0m▼ 1.8%
Working capital€0.2mwithin the sector's middle half-€0.2mwithin the sector's middle half▲ 11.9%€0.3mwithin the sector's middle half▲ 14.1%€0.3mwithin the sector's middle half▼ 0.6%
Solvency37.5%within the sector's middle half-54.7%within the sector's middle half▲ 17.2pp26.4%within the sector's middle half▼ 28.3pp26.4%within the sector's middle half=
Current ratio2.93above the sector's middle half-3.36above the sector's middle half▲ 0.432.80within the sector's middle half▼ 0.563.92above the sector's middle half▲ 1.12
Return on assets (ROA)36.2%above the sector's middle half-24.0%above the sector's middle half▼ 12.2pp7.1%within the sector's middle half▼ 16.8pp-0.5%below the sector's middle half▼ 7.6pp
Staff (FTE)0.4below the sector's middle half-1below the sector's middle half▲ 150%1below the sector's middle half=2within the sector's middle half▲ 100%
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.3m
Fixed assets €991,306 ▲ 3.5%
Current assets €348,666 ▼ 14.3%
Equity and liabilities €1.3m
Equity €353,392 ▼ 1.8%
Debt €986,579 ▼ 1.8%
Debt's share of the balance-sheet total stays at 73.6%.
Key figures and ratios
2025 value · change against 2024
EBITDA
€28,060▼
2024 · €177,640
Cash flow
€25,274▼
2024 · €125,511
Quick ratio
1.56▲
2024 · 1.18
Debt to equity
2.79=
2024 · 2.79
ROE
-1.8%▼
2024 · 27.0%
Interest coverage
14.62▼
2024 · 51.88
Debt ≤ 1 year
€88,890▼
2024 · €145,416
Debt > 1 year
€897,690▲
2024 · €859,353
Income taxes
€866▼
2024 · €48,705
Staff costs
€162,690▲
2024 · €66,540
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.4m€1.3m▼
Fixed assets21/28€1.0m€1.0m▲
Tangible fixed assets22/27€0.1m€0.1m▼
Plant, machinery and equipment23€0.04m€0.03m▼
Furniture and vehicles24€0.1m€0.07m▼
Financial fixed assets28€0.8m€0.9m▲
Current assets29/58€0.4m€0.3m▼
Stocks and contracts in progress3€0.2m€0.2m▼
Stocks30/36€0.2m€0.2m▼
Amounts receivable within one year40/41€0.1m€0.08m▼
Trade receivables40€0.09m€0.05m▼
Other amounts receivable41€0.06m€0.03m▼
Cash at bank and in hand54/58€0.03m€0.06m▲
Deferred charges and accrued income490/1€157€0.002m▲
Equity and liabilities
Total equity and liabilities10/49€1.4m€1.3m▼
Equity10/15€0.4m€0.4m▼
Contributions10/11€0.005m€0.005m=
Reserves13€0.4m€0.4m=
Distributable reserves133€0.4m€0.4m=
Profit (loss) carried forward14--€0.006m
Amounts payable17/49€1.0m€1.0m▼
Amounts payable after more than one year17€0.9m€0.9m▲
Financial debts170/4€0.02m-
Other amounts payable178/9€0.8m€0.9m▲
Amounts payable within one year42/48€0.1m€0.09m▼
Current portion of amounts payable after more than one year42€0.02m€0.02m▼
Trade debts44€0.1m€0.05m▼
Suppliers440/4€0.1m€0.05m▼
Taxes, remuneration and social security45€0.02m€0.02m▲
Taxes450/3€0.01m€0.004m▼
Remuneration and social security454/9€0.009m€0.02m▲
Income statement Code20242025
Remuneration, social security and pensions62€0.07m€0.2m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.03m€0.03m▲
Other operating charges640/8€0.001m€0.001m▼
Gross operating margin9900€0.2m€0.2m▼
Operating profit (loss)9901€0.1m-€0.004m▼
Financial charges65/66B€0.003m€0.002m▼
Recurring financial charges65€0.003m€0.002m▼
Profit (loss) for the period before taxes9903€0.1m-€0.006m▼
Income taxes67/77€0.05m€0.001m▼
Profit (loss) for the period9904€0.1m-€0.006m▼
Profit (loss) for the period to be appropriated9905€0.1m-€0.006m▼
Appropriation of the result
Profit (loss) to be appropriated9906€0.1m-€0.006m▼
Transfer to equity691/2€0.1m-
To other reserves6921€0.1m-
Social balance sheet
Average headcount (FTE)90871.02.0▲

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Remuneration, social security and pensions62€25,656€68,630€66,540€162,690▲ 144%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9,848€15,748€28,245€31,711▲ 12.3%
Other operating charges640/8€62€423€1,021€700▼ 31.4%
Gross operating margin9900€234,312€249,994€245,201€191,450▼ 21.9%
Operating profit (loss)9901€198,746€165,193€149,395-€3,651-
Financial charges65/66B€807€1,920€3,424€1,919▼ 43.9%
Recurring financial charges65€807€1,920€3,424€1,919▼ 43.9%
Profit (loss) for the period before taxes9903€197,939€163,273€145,971-€5,570-
Income taxes67/77€55,533€48,116€48,705€866▼ 98.2%
Profit (loss) for the period9904€142,406€115,157€97,266-€6,436-
Profit (loss) for the period to be appropriated9905€142,406€115,157€97,266-€6,436-
Line2022202320242025Change
Assets
Total assets20/58€0.4m€0.5m€1.4m€1.3m▼ 1.8%
Fixed assets21/28€0.08m€0.2m€1.0m€1.0m▲ 3.5%
Tangible fixed assets22/27€0.07m€0.1m€0.1m€0.1m▼ 23.4%
Plant, machinery and equipment23€0.04m€0.04m€0.04m€0.03m▼ 13.8%
Furniture and vehicles24€0.02m€0.09m€0.1m€0.07m▼ 27.2%
Financial fixed assets28€0.02m€0.02m€0.8m€0.9m▲ 7.9%
Current assets29/58€0.3m€0.3m€0.4m€0.3m▼ 14.3%
Stocks and contracts in progress3€0.1m€0.2m€0.2m€0.2m▼ 10.4%
Stocks30/36€0.1m€0.2m€0.2m€0.2m▼ 10.4%
Amounts receivable within one year40/41€0.04m€0.05m€0.1m€0.08m▼ 47.9%
Trade receivables40€0.03m€0.05m€0.09m€0.05m▼ 47.1%
Other amounts receivable41€0.008m-€0.06m€0.03m▼ 49.0%
Cash at bank and in hand54/58€0.1m€0.08m€0.03m€0.06m▲ 139%
Deferred charges and accrued income490/1--€157€0.002m▲ 985%
Equity and liabilities
Total equity and liabilities10/49€0.4m€0.5m€1.4m€1.3m▼ 1.8%
Equity10/15€0.1m€0.3m€0.4m€0.4m▼ 1.8%
Contributions10/11€0.005m€0.005m€0.005m€0.005m=
Reserves13€0.1m€0.3m€0.4m€0.4m=
Distributable reserves133€0.1m€0.3m€0.4m€0.4m=
Profit (loss) carried forward14----€0.006m-
Amounts payable17/49€0.2m€0.2m€1.0m€1.0m▼ 1.8%
Amounts payable after more than one year17€0.1m€0.1m€0.9m€0.9m▲ 4.5%
Financial debts170/4-€0.04m€0.02m--
Other amounts payable178/9€0.1m€0.08m€0.8m€0.9m▲ 6.6%
Amounts payable within one year42/48€0.1m€0.1m€0.1m€0.09m▼ 38.9%
Current portion of amounts payable after more than one year42-€0.02m€0.02m€0.02m▼ 22.2%
Trade debts44€0.04m€0.03m€0.1m€0.05m▼ 53.5%
Suppliers440/4€0.04m€0.03m€0.1m€0.05m▼ 53.5%
Taxes, remuneration and social security45€0.07m€0.04m€0.02m€0.02m▲ 17.4%
Taxes450/3€0.06m€0.03m€0.01m€0.004m▼ 65.4%
Remuneration and social security454/9€0.008m€0.01m€0.009m€0.02m▲ 114%
Line2022202320242025Change
Profit (loss) for the period9904€142,406€115,157€97,266-€6,436-
+ Depreciation and write-downs630€9,848€15,748€28,245€31,711▲ 12.3%
Operating cash flow (approximation)€152,253€130,905€125,511€25,274▼ 79.9%
Investment in fixed assets (approximation)--€87,348-€831,906-€65,229▲ 92.2%
Change in cash--€49,773-€59,287€35,041-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
30-09-2025 abbreviated format 04-12-2025 2025-00576804
30-09-2024 abbreviated format 13-12-2024 2024-00615787
30-09-2023 abbreviated format 08-01-2024 2024-00544912
30-09-2022 abbreviated format 20-03-2023 2023-00042641

Similar companies · same sector, comparable size

Of the 5,202 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,874. 3,471 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.